Total Payments
$621,909
2024 Payments
$2,129
Companies
10
Transactions
840
Medicare Patients
181
Medicare Billing
$62,169
Payment Breakdown by Category
Other$458,524 (73.7%)
Travel$118,464 (19.0%)
Consulting$22,723 (3.7%)
Food & Beverage$22,181 (3.6%)
Education$17.34 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $458,524 | 248 | 73.7% |
| Travel and Lodging | $118,464 | 256 | 19.0% |
| Consulting Fee | $22,723 | 6 | 3.7% |
| Food and Beverage | $22,181 | 326 | 3.6% |
| Education | $17.34 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $327,555 | 467 | $0 (2024) |
| Alkermes, Inc. | $130,023 | 146 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $60,899 | 69 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $49,452 | 46 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $25,914 | 44 | $0 (2023) |
| Indivior Inc. | $17,874 | 28 | $0 (2020) |
| Allergan Inc. | $9,593 | 34 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $231.11 | 2 | $0 (2023) |
| ABBVIE INC. | $211.50 | 2 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $157.11 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,129 | 6 | Janssen Pharmaceuticals, Inc ($2,129) |
| 2023 | $105,563 | 149 | Janssen Pharmaceuticals, Inc ($75,968) |
| 2022 | $150,973 | 181 | Janssen Pharmaceuticals, Inc ($68,454) |
| 2021 | $69,076 | 84 | Janssen Pharmaceuticals, Inc ($53,156) |
| 2020 | $22,518 | 42 | Indivior Inc. ($9,466) |
| 2019 | $100,909 | 140 | Janssen Pharmaceuticals, Inc ($51,763) |
| 2018 | $99,480 | 129 | Sunovion Pharmaceuticals Inc. ($49,448) |
| 2017 | $71,262 | 109 | Janssen Pharmaceuticals, Inc ($40,297) |
All Payment Transactions
840 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $44.54 | General |
| Category: Neuroscience | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| Category: Neuroscience | ||||||
| 03/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $1,004.71 | General |
| Category: Neuroscience | ||||||
| 01/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: Neuroscience | ||||||
| 01/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $132.99 | General |
| Category: Neuroscience | ||||||
| 01/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $22.27 | General |
| Category: Neuroscience | ||||||
| 12/29/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $46.34 | General |
| Category: Neuroscience | ||||||
| 12/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $22.27 | General |
| Category: Neuroscience | ||||||
| 12/26/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $163.75 | General |
| Category: Neuroscience | ||||||
| 12/26/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $163.75 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $775.50 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $275.00 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $163.88 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $158.62 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $119.64 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| Category: Neuroscience | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | Cash or cash equivalent | $44.54 | General |
| Category: Neuroscience | ||||||
| 12/18/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Neuroscience | ||||||
| 12/15/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Travel and Lodging | In-kind items and services | $211.81 | General |
| Category: Neuroscience | ||||||
| 12/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Neuroscience | ||||||
| 12/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 34 | $13,635 | $2,513 |
| 2022 | 1 | 38 | 199 | $84,952 | $19,634 |
| 2021 | 2 | 65 | 237 | $87,149 | $23,783 |
| 2020 | 1 | 49 | 185 | $66,261 | $16,239 |
Total Patients
181
Total Services
655
Medicare Billing
$62,169
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $2,092 | $1,301 | 62.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 17 | $11,543 | $1,212 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 199 | $84,952 | $19,634 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 225 | $85,099 | $22,896 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $2,049 | $887.59 | 43.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 185 | $66,261 | $16,239 | 24.5% |
About Dr. Latha Nair, M.D
Dr. Latha Nair, M.D is a Psychiatry healthcare provider based in Santa Cruz, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164527560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Latha Nair, M.D has received a total of $621,909 in payments from pharmaceutical and medical device companies, with $2,129 received in 2024. These payments were reported across 840 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($458,524).
As a Medicare-enrolled provider, Nair has provided services to 181 Medicare beneficiaries, totaling 655 services with total Medicare billing of $62,169. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Santa Cruz, CA
- Active Since 09/13/2006
- Last Updated 08/31/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1164527560
Products in Payments
- INVEGA SUSTENNA (Drug) $267,443
- LATUDA (Drug) $60,843
- INVEGA TRINZA (Drug) $58,604
- ARISTADA (Drug) $55,307
- INGREZZA (Drug) $49,452
- Aristada 441 mg (Drug) $42,333
- LYBALVI (Drug) $32,383
- REXULTI (Drug) $25,496
- PERSERIS (Drug) $17,794
- VRAYLAR (Drug) $9,804
- INVEGA (Drug) $1,175
- ABILIFY MAINTENA (Drug) $412.52
- SPRAVATO (Drug) $333.00
- UZEDY (Drug) $117.90
- AUSTEDO (Drug) $113.21
- ABILIFY ASIMTUFII (Drug) $103.78
- SUBLOCADE (Drug) $80.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Santa Cruz
Dr. Catherine Borchert, Md, MD
Psychiatry — Payments: $7,664
Psychiatry $7,664
Dr. Sreekumar Nair, M.d, M.D
Psychiatry — Payments: $5,098
Psychiatry $5,098
Katherine Yarborough, Do, DO
Psychiatry — Payments: $3,257
Psychiatry $3,257
Paul Luther, M.d, M.D
Psychiatry — Payments: $1,906
Psychiatry $1,906
Danit Bar Ziv, Md, MD
Psychiatry — Payments: $1,657
Psychiatry $1,657
Pranathi Mruthyunjaya, M.d, M.D
Psychiatry — Payments: $1,526
Psychiatry $1,526